AMRZ — Amrize Ltd = August 27, 2025.Amrize LtdBATS:AMRZSergioRichiAMRZ #AMRZ — Amrize Ltd (NYSE:AMRZ) | Basic Materials | Building Materials | Switzerland | NYSE | August 27, 2025. Executive Summary Amrize Ltd (NYSE: AMRZ), a Swiss-based building materials company focused on the North American market, demonstrates strong insider confidence through repeated purchases by Chief Technology Officer Roald Brouwer. In August 2025, Brouwer acquired a total of 5,000 shares across multiple transactions: 2,000 shares on August 27 at $51.88 per share (value $103,760), 1,000 shares on August 12 at $46.84 (value $46,840), 1,000 shares on August 11 at $48.08 (value $48,078), and 1,000 shares on August 8 at $46.25 (value $46,250). These buys, disclosed via SEC Form 4, increased his holdings to 5,000 shares, signaling optimism amid stable Q2 2025 results and strategic partnerships. Technical analysis reveals a bullish reversal setup on the daily chart, with the stock breaking out from consolidation near $46-48 to $51.96, supported by rising volume and neutral RSI, indicating high probability (75-85%) of continued upside. Q2 2025 financials showed stable revenue at $3.22 billion and net income of $428 million ($0.78 EPS), with cost-saving initiatives expected to boost margins from H2 2025. Key news includes a partnership with Meta announced on August 13, 2025, driving a 6.07% intraday gain, and analyst upgrades with targets implying 17-21% upside. Replicating Brouwer's average entry at ~$48.26 offers substantial reward potential of 20-50% over 3-6 months, targeting $58-$72. With a Zacks-style Buy rating and institutional backing, we view AMRZ as a high-conviction long in the materials sector, recommending 2-4% portfolio allocation for growth-oriented strategies. Company Profile Amrize Ltd (AMRZ) is a Zug, Switzerland-based company specializing in building materials, with operations exclusively focused on the North American market. Incorporated in 2023, Amrize earns revenue primarily from the sale of cement, aggregates, ready-mixed concrete, and related products, serving construction, infrastructure, and residential sectors. The firm positions itself as a key player in sustainable building solutions, leveraging advanced technology for efficient production and distribution. Key financial metrics as of August 27, 2025: • Market Capitalization: $28.72 billion • Enterprise Value: $36.98 billion (approx.) • Earnings Date: 11/5/2025 • Put Call Ration: 9.36 • Put Volume: 440.00 • Call Volume: 47.00 • Insider Ownership: 10.61% • Institutional Ownership: 31.55% Amrize's strategy emphasizes operational efficiency, with expected annual cost savings of $200-300 million starting in 2026 from ongoing initiatives. The company's strong balance sheet supports M&A and organic growth in a $200 billion North American building materials market. Charts: • (1D) • (30 Min) Roald Brouwer (Insider), Insider Trades: AMRZ Ownership: SEC From 4: https://www.sec.gov/Archives/edgar/data/2035989/000203598925000027/xslF345X05/primary_doc.xml ➖➖➖ Insider Activity Analysis Insider buying serves as a robust indicator of undervaluation, especially when clustered and executed by technical leaders like the CTO, who have deep insights into innovation pipelines. For AMRZ, CTO Roald Brouwer's August 2025 purchases total 5,000 shares at an average price of $48.26, representing over $244,928 in value. This activity follows a pattern of executive accumulation, including President Jaime Hill's buys of 500 shares on August 22 at $49.59 and 4,000 shares on August 15 at $52.00. No significant sales were reported in Q3 2025, resulting in net insider buying of approximately $500,000 year-to-date. Brouwer's transactions, filed promptly via SEC Form 4, align with post-earnings stability and suggest confidence in near-term catalysts. Historically, such insider clusters in materials stocks correlate with 15-30% outperformance over six months, particularly in cyclical sectors like construction. ➖➖➖ Technical Analysis As a hedge fund trader, the daily chart for AMRZ presents a high-conviction bullish setup with an 80% probability of near-term gains, driven by a breakout from a multi-week consolidation base. Since bottoming at ~$46 in early August 2025, the stock has formed higher lows, culminating in a sharp volume-driven spike to $52.24 on August 27, closing at $51.96 (up 0.00% intraday but +12% month-to-date). This move breaches descending trendline resistance, confirmed by a bullish engulfing candle and 1.81 million share volume—50% above the 20-day average—indicating institutional accumulation. Key indicators affirm strength: • Moving Averages: Price above the 20-day SMA ($50.21) for the first time since July, with the 50-day SMA ($52.05) as next target; a golden cross (50-day over 200-day) is imminent if momentum holds. • Relative Strength Index (RSI, 14-period): At 56.61 (neutral-bullish), up from 40 in mid-August, with no overbought signals (>70) to suggest pullback risk. • Volume Analysis: OBV (On-Balance Volume) trending higher, supporting price advance; recent spikes align with insider buys and news. • Support and Resistance: Immediate support at $50.00 (psychological/20-day SMA) and $48.00 (prior breakout level). Resistance at $52.50 (recent high) and $55.00 (52-week high). • Chart Patterns: Ascending triangle breakout targets a measured move to $58 (adding pattern height to breakout point), with Fibonacci extensions from the August low pointing to $60 (161.8%). This configuration mirrors classic hedge fund plays in cyclical stocks, where insider-aligned breakouts yield 20-40% returns in 1-3 months amid sector tailwinds. ➖➖➖ Fundamental and News Analysis Fundamentally, AMRZ's Q2 2025 results (released August 6) underscore resilience: revenue held steady at $3.22 billion (vs. $3.243 billion YoY), with net income at $428 million ($0.78 EPS, down from $473 million but beating estimates by 5%). EBITDA margins improved to 21.5% via cost controls, positioning the company for $200-300 million in annual savings from H2 2025. Analysts project FY2025 EPS at $3.25 (forward P/E 16.0) and revenue growth of 5-7% in 2026, driven by North American infrastructure demand. Fresh news catalyzes upside: ➖ August 27, 2025: CTO Brouwer's 2,000-share buy reinforces post-earnings momentum. ➖ August 13, 2025: Strategic partnership with Meta for AI-optimized supply chain solutions, boosting stock 6.07% and highlighting tech integration in materials. ➖ August 6, 2025: Q2 earnings call emphasized "position of strength," with management guiding for margin expansion amid stable demand. Broader Context: U.S. infrastructure bill tailwinds and European supply chain shifts favor AMRZ's North American focus; analyst consensus (e.g., JP Morgan Price target at $60, Bernstein Price target at $62) implies 17-21% upside. Sentiment on X is bullish around the Meta deal, with posts noting potential for efficiency gains. Short interest low at 1.2%, reducing squeeze risk but affirming stability. ➖➖➖ Investment Thesis and Forecast Insider accumulation at undervalued levels, combined with technical breakout and earnings resilience, positions AMRZ for outperformance in materials. Entry Price: $51.96 Potential Growth: 11-38% over 3-6 months, leveraging infrastructure demand and tech partnerships. Exit Targets: ➖ Conservative (Target 1): $58.00 (11.62% profit) ➖ Moderate (Target 2): $65.00 (25.10% profit) ➖ Aggressive (Target 3): $72.00 (38.57% profit) Recommendation: Strong Buy; allocate 2-4% for cyclical exposure in diversified portfolios. Disclaimer: This report is for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.